{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02953834",
            "orgStudyIdInfo": {
                "id": "2016P001769"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Kisspeptin Influence on Glucose Homeostasis",
            "officialTitle": "Kisspeptin Influence on Glucose Homeostasis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "kisspeptin-influence-on-glucose-homeostasis"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-07-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-11-01",
            "studyFirstSubmitQcDate": "2016-11-01",
            "studyFirstPostDateStruct": {
                "date": "2016-11-03",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2023-07-17",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Stephanie B. Seminara, MD",
                "investigatorTitle": "Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, MGH Harvard Center for Reproductive Medicine",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Stephanie B. Seminara, MD",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to learn about how a naturally occurring hormone called kisspeptin affects blood sugar and insulin levels."
        },
        "conditionsModule": {
            "conditions": [
                "Impaired Glucose Tolerance",
                "Hypogonadism"
            ],
            "keywords": [
                "insulin regulation in pregnancy",
                "kisspeptin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 413,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Kisspeptin and Insulin Resistance Test",
                    "type": "EXPERIMENTAL",
                    "description": "Intravenous (IV) administration of kisspeptin 112-121; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose",
                    "interventionNames": [
                        "Drug: kisspeptin 112-121",
                        "Other: Insulin Resistance Test"
                    ]
                },
                {
                    "label": "Placebo and Insulin Resistance Test",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "IV administration of fluids that contain no study drug; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose",
                    "interventionNames": [
                        "Other: Insulin Resistance Test",
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "kisspeptin 112-121",
                    "description": "Dose: 0.313-12.5 mcg/kg Duration: up to 16 hours",
                    "armGroupLabels": [
                        "Kisspeptin and Insulin Resistance Test"
                    ],
                    "otherNames": [
                        "metastin 45-54"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Insulin Resistance Test",
                    "description": "Eat or drink a standard meal OR drink a standard drink containing 75 grams of sugar",
                    "armGroupLabels": [
                        "Kisspeptin and Insulin Resistance Test",
                        "Placebo and Insulin Resistance Test"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Receive IV fluids for up to 16 hours that do not contain any study drug",
                    "armGroupLabels": [
                        "Placebo and Insulin Resistance Test"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Average difference in area under the curve of insulin in response to a mixed meal tolerance test",
                    "description": "Compares difference on and off kisspeptin",
                    "timeFrame": "4 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Average difference in area under the curve of glucose in response to a mixed meal tolerance test",
                    "description": "Compares difference on and off kisspeptin",
                    "timeFrame": "4 hours"
                },
                {
                    "measure": "Average difference in area under the curve of glucagon-like peptide 1 in response to a mixed meal tolerance test",
                    "description": "Compares difference on and off kisspeptin",
                    "timeFrame": "4 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion/Exclusion Criteria:\n\nHistory:\n\n* normal pubertal development\n* stable weight for previous three months\n* no active illicit drug use,\n* no history of a medication reaction requiring emergency medical care,\n* no difficulty with blood draws.\n\nPhysical examination:\n\n\u2022 systolic BP \\< 140 mm Hg, diastolic \\< 90 mm Hg,\n\nLaboratory studies: (per MGH reference ranges)\n\n* normal hemoglobin, unless hypogonadal then no lower than 0.5 gm/dL below the lower limit of the reference range for normal women (as men and women with hypogonadism have lower hemoglobin levels off of treatment)\n* hemoglobin A1C \\< 6.5%\n* BUN, creatinine not elevated\n* AST, ALT \\< 3x upper limit of normal\n* negative serum pregnancy test (for all women)\n* no hyperlipidemia by fasting lipid panel\n\nAdditional Criteria by Study Population\n\nHealthy Men:\n\n* normal body mass index (BMI between 18.5-25)\n* no history of chronic disease, except well controlled thyroid disease\n* no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine or seasonal allergy medications is acceptable.\n* no history of diabetes in a first degree relative.\n\nHealthy Women:\n\n* normal body mass index (BMI between 18.5-25)\n* no history of chronic disease, except well controlled thyroid disease,\n* no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine or seasonal allergy medications is acceptable.\n* no history of diabetes in a first degree relative,\n* no use of contraceptive pills, patches or vaginal rings within last 4 weeks.\n* regular menstrual cycles\n\nPostmenopausal Women:\n\n* body mass index (BMI between 18.5-30)\n* no history of chronic disease except thyroid disease, and osteoporosis,\n* no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine, osteoporosis medications or seasonal allergy medications is acceptable,\n* no history of diabetes in a first degree relative,\n* normal activate protein C resistance screen,\n* if applicable, able to undergo appropriate washout from hormone therapy.\n\nMen and Women with Impaired Glucose Tolerance (IGT):\n\n* diagnosis of impaired glucose tolerance by oral glucose tolerance test,\n* all medical conditions well-controlled.\n\nMen and Women with Hypogonadism\n\n* diagnosis of hypogonadism,\n* all other medical conditions well-controlled,\n* if applicable, able to undergo appropriate washout from hormone therapy.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Margaret Lippincott, MD",
                    "role": "CONTACT",
                    "phone": "617-726-8434",
                    "email": "mlippincott@partners.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Margaret Lippincott, MD",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Margaret Lippincott, MD",
                            "role": "CONTACT",
                            "phone": "617-726-8434",
                            "email": "mlippincott@partners.org"
                        },
                        {
                            "name": "Margaret Lippincott, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Stephanie Seminara, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "After primary results are published, the authors will provide individuals participant data upon request as long as it does not conflict with state or Institutional regulations."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018149",
                    "term": "Glucose Intolerance"
                },
                {
                    "id": "D000007006",
                    "term": "Hypogonadism"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006943",
                    "term": "Hyperglycemia"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20295",
                    "name": "Glucose Intolerance",
                    "asFound": "Impaired Glucose Tolerance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10056",
                    "name": "Hypogonadism",
                    "asFound": "Hypogonadism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9994",
                    "name": "Hyperglycemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007328",
                    "term": "Insulin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "asFound": "Day 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}